Related Experiment Video

Updated: Jul 18, 2025

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.8K

Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges

Lorenza Pastorino1,2, Paola Ghiorzo1,2, William Bruno1,2

  • 1Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, L.go R. Benzi X, 16132 Genoa, Italy.

Cancers
|August 26, 2023
PubMed

Abstract:

Pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive malignancies in industrialized countries, is predicted to become the second leading cause of cancer deaths by 2040 [...].

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

843
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.8K

Related Experiment Videos

Last Updated: Jul 18, 2025

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.8K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

843
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.8K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

Articles linked to this work by shared authors, journal, and citation graph.

A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility.

Research square·2026

Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI).

Pigment cell & melanoma research·2026

Synchronous Cardiac Fibroma and Medulloblastoma in Gorlin Syndrome: A Paradigmatic Case and Narrative Review.

Children (Basel, Switzerland)·2025

Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma.

International journal of molecular sciences·2025

Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 Patients.

Journal of clinical medicine·2025

Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.

Journal of translational medicine·2024

Correction: García-Delgado et al. Translational Insights into Interferon Alpha's Effects on Immunomolecular Dynamics in Philadelphia-Negative Myeloproliferative Neoplasms. Cancers 2025, 17, 2273.

Cancers·2026

Correction: Volkova et al. Anaplastic Large Cell Lymphoma in Children: 20-Year Immune-Oriented Treatment Experience. Cancers 2026, 18, 1583.

Cancers·2026

Correction: Zaffalon et al. Dilemmas in the Clinical Management of pT1 Colorectal Cancer. Cancers 2023, 15, 3511.

Cancers·2026

Correction: Kania et al. Evaluating the Transition from 3D Laparoscopy to Robotic Partial Nephrectomy: Trifecta Achievement and Nephrometry Score Differences. Cancers 2025, 17, 3976.

Cancers·2026

Correction: Kühn et al. HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction? Cancers 2021, 13, 4730.

Cancers·2026

Lymphatic Microvascular Density, Lymphatic Invasion and Endothelial Cell Proliferation as Prognostic Biomarkers in Cutaneous Melanoma: A Systematic Review and Evidence Map.

Cancers·2026

Correction to: 'Exposure of male mice to nicotine leads to metabolic dysfunction in their male and female offspring'.

Journal of the Endocrine Society·2026

Familial Congenital Hypothyroidism due to Compound Heterozygous Variants in the TPO Gene: Neonatal Diagnosis, Phenotypic Variability, and Lessons From Long-Term Follow-Up in Three Brothers.

Case reports in genetics·2026

Metformin Attenuates Glucose-Driven Hepatocellular Carcinoma Progression by Targeting GPD2-Mediated Metabolic Plasticity.

Scientifica·2026

From missed diagnosis to lifelong survivorship: a precision oncology roadmap for equity in pediatric and AYA cancer care.

Frontiers in oncology·2026

Cancer Evolvability Determines Therapy Outcomes.

Evolutionary applications·2026

Beyond mutation burden: biological termination as a systems perspective on cancer.

Frontiers in cell and developmental biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us